Chevreau Julien, Krief David, Abou Arab Osama, Zitoun Mickaël, Foulon Arthur, Sergent Fabrice, Gondry Jean
Amiens-Picardie University Hospital, France.
Amiens-Picardie University Hospital, France.
Eur J Obstet Gynecol Reprod Biol. 2018 May;224:81-84. doi: 10.1016/j.ejogrb.2018.03.019. Epub 2018 Mar 13.
Nexplanon's new applicator system was designed to limit deep implant placements, known to lead to difficult removals. However, removal difficulties still exist and induce specific and potentially severe complications. Our objective was to identify risk factors associated with difficult removals.
A retrospective single-center study was performed from January 2015 to December 2016. Participants were divided into two groups depending on whether implant was removed during a standard ("standard removal" group) or difficult consultation ("difficult removal" group) after an initial failed removal attempt.
The difficult and standard removal groups comprised 63 and 660 women, respectively. In a univariate analysis, significant intergroup differences were found for weight gain (3.7 ± 7.3 kg in the difficult removal group vs. 1.3 ± 5.1 in the standard removal group), proportion of placements performed in private practice (66.7% vs. 19.8%, respectively), and duration of Nexplanon placement (29.4 ± 11.3 months versus 26 ± 13.6, respectively). We also reported more frequent sub-brachial fascia placements when Nexplanon was implanted by a private practitioner (7.5% cases versus 0.4% in hospital implantations, p < 0.001). In a stepwise binary logistic regression analysis, placement by a private practitioner, weight gain >1 kg since placement, and duration of implant placement >25 months were confirmed as independent risk factors for removal difficulties (respective risk ratios 7.63 [95% IC 4.35-13.33], 2.10 [1.18-3.70], and 1.91 [1.06-3.44], p < 0.05).
Awareness of these three simple parameters might help physicians to identify "at risk-patients", and suggest a specific consultation before risking a potentially hazardous removal (with its associated, specific morbidity). Our results also emphasize importance of training in implant insertion.
Nexplanon新型植入器系统旨在减少深部植入,因为深部植入会导致取出困难。然而,取出困难仍然存在,并会引发特定的、可能严重的并发症。我们的目的是确定与取出困难相关的风险因素。
2015年1月至2016年12月进行了一项回顾性单中心研究。根据初次取出尝试失败后,植入物是在标准会诊(“标准取出”组)还是困难会诊(“困难取出”组)期间取出,将参与者分为两组。
困难取出组和标准取出组分别包括63名和660名女性。在单因素分析中,发现两组在体重增加方面存在显著差异(困难取出组为3.7±7.3千克,标准取出组为1.3±5.1千克)、私人诊所进行植入的比例(分别为66.7%和19.8%)以及Nexplanon植入持续时间(分别为29.4±11.3个月和26±13.6个月)。我们还报告称,当由私人执业医生植入Nexplanon时,肱下筋膜下植入更为频繁(7.5%的病例,而医院植入为0.4%,p<0.001)。在逐步二元逻辑回归分析中,私人执业医生植入、植入后体重增加>1千克以及植入持续时间>25个月被确认为取出困难的独立风险因素(风险比分别为7.63[95%置信区间4.35 - 13.33]、2.10[1.18 - 3.70]和1.91[1.06 - 3.44],p<0.05)。
了解这三个简单参数可能有助于医生识别“高危患者”,并在进行可能有风险的取出操作(及其相关的特定发病率)之前建议进行特定会诊。我们的结果还强调了植入培训的重要性。